Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
Rhea-AI Summary
Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services, has scheduled its second quarter 2025 financial results announcement for Monday, August 11, 2025, after market close.
The company will host a conference call and webcast at 2:00 p.m. PT/ 5:00 p.m. ET on the same day. Investors can join via phone by dialing (800) 267-6316 or (203) 518-9783 with Conference ID MARAVAI, or access the webcast through the "Investors" section of Maravai's website.
Positive
- None.
Negative
- None.
News Market Reaction 2 Alerts
On the day this news was published, MRVI declined 6.42%, reflecting a notable negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $49M from the company's valuation, bringing the market cap to $719M at that time.
Data tracked by StockTitan Argus on the day of publication.
SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2025 financial and operating results after the market close on Monday, August 11, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial (800) 267-6316 or (203) 518-9783 and reference Maravai LifeSciences, Conference ID MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
Contact Information: Deb Hart Maravai LifeSciences + 1 858-988-5917 ir@maravai.com
FAQ
When will Maravai LifeSciences (MRVI) release Q2 2025 earnings?
What time is Maravai LifeSciences Q2 2025 earnings call?
How can I access Maravai LifeSciences (MRVI) Q2 2025 earnings call?
What does Maravai LifeSciences (MRVI) do?
